Skip to main content
. Author manuscript; available in PMC: 2021 Jan 18.
Published in final edited form as: Expert Rev Vaccines. 2020 Mar 17;19(2):175–194. doi: 10.1080/14760584.2020.1732215

Figure 1:

Figure 1:

Vaccine patch development pathway and intensity of efforts (indicated by triangles) required from stakeholders that need to resolve key issues and converge to commercialize a clinical vaccine patch, including successful handoff from patch developers to vaccine manufacturers.